Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Specify a stock or a cryptocurrency in the search bar to get a summary
Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Amylyx Pharmaceuticals Inc
AMLXCurrent price
5.02 USD
-0.3 USD (-5.64%)
Last closed
5.68 USD
Company
amylyx.com
ISIN
US0321085088
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Capitalization
459 270 944 USD
Yield for 12 month
-61.62 %
1Y
3Y
5Y
10Y
15Y
AMLX
Amylyx Pharmaceuticals, Inc., a commercial-stage biotechnology company, engages in the discovery and development of treatment for amyotrophic lateral sclerosis (ALS) and neurodegenerative diseases. The company's products include RELYVRIO, a dual UPR-Bax apoptosis inhibitor composed of sodium phenylbutyrate and taurursodiol for the treatment of ALS in adults in the United States and marketed as ALBRIOZA for the treatment of ALS in Canada. It is also developing AMX0114 for other neurodegenerative diseases. Amylyx Pharmaceuticals, Inc. was founded in 2013 and is headquartered in Cambridge, Massachusetts. Address: 43 Thorndike Street, Cambridge, MA, United States, 02141
Check your investment idea
Find the best to beat the market
TSLA
Tesla Motors
AAPL
Apple
MSFT
Microsoft
Analytics
WallStreet Target Price
6.17 USDP/E ratio
–Dividend Yield
–Current Year
+380 786 000 USD
Last Year
+22 230 000 USD
Current Quarter
+416 000 USD
Last Quarter
-1 022 999 USD
Current Year
+355 345 000 USD
Last Year
+19 237 000 USD
Current Quarter
-393 000 USD
Last Quarter
-8 648 999 USD
Key Figures AMLX
1 year
3 years
5 years
10 years
EBITDA
-212 164 000 USD
Operating Margin TTM
PE Ratio
–
Return On Assets TTM
-37.13 %
PEG Ratio
–
Return On Equity TTM
-84.43 %
Wall Street Target Price
6.17 USD
Revenue TTM
196 484 992 USD
Book Value
2.88 USD
Revenue Per Share TTM
Dividend Share
–
Quarterly Revenue Growth YOY
-99.6 %
Dividend Yield
–
Gross Profit TTM
-74 213 000 USD
Earnings per share
-3.82 USD
Diluted Eps TTM
-3.82 USD
Most Recent Quarter
III 2024
Quarterly Earnings Growth YOY
–
Profit Margin
-132.05 %
Dividend Analytics AMLX
Dividend growth over 5 years
–Continuous growth
–Payout Ratio 5 years average
–Dividend History AMLX
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
–
Ex Dividend Date
–
Forward Annual Dividend Yield
–
Last Split Factor
–
Payout Ratio
–
Last Split Date
–
Dividend Date
–
Stock Valuation AMLX
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
–
Forward PE
2.7739
Enterprise Value Revenue
1.161
Price Sales TTM
1.5372
Enterprise Value EBITDA
-11.707
Price Book MRQ
2.3443
Financials AMLX
1 year
3 years
5 years
10 years
15 years
| Results | 2019 | Dynamics |
* The data for this period has not yet been published
Technical indicators AMLX
For 52 weeks
1.58 USD
19.95 USD
50 Day MA
3.76 USD
Shares Short Prior Month
1 279 759
200 Day MA
4.65 USD
Short Ratio
0.76
Shares Short
1 010 282
Short Percent
1.63 %
BeatStart